Analysis & Purification of Therapeutic Oligonucleotides: Method Development Optimization from the Analytical Scale Through Semi-prep and Preparative Purification

Connor Flannery1, Jordy Hsiao1 Andrea Angelo P. Tripodi2, Andrew Coffey2 Analysis & Purification of Therapeutic Oligonucleotides: Method development optimization from the analytical scale through semi-prep and preparative purification 1Agilent Technologies, Santa Clara, CA HPLC 2024 POSTER # 275 2Agilent Technologies,…

An Introduction to Ion-Paired Reverse-Phase Oligonucleotide Separations: From Analysis to Purification Melissa Goodlad, PhD Columns and Supplies Applications Engineer April 15, 2025 1 April 15, 2025 An Introduction to Ion-Paired Reverse-Phase Oligonucleotide Separations DE-006001 Introduction to Ion-Paired Reverse-Phase (IP-RP) Separations…

An Introduction to Ion-Paired Reverse-Phase Oligonucleotide Separations: From Analysis to Purification Melissa Goodlad, PhD Columns and Supplies Applications Engineer April 15, 2025 1 April 15, 2025 An Introduction to Ion-Paired Reverse-Phase Oligonucleotide Separations DE-006001 Introduction to Ion-Paired Reverse-Phase (IP-RP) Separations…

Image © Agilent Technologies, Inc. 2024 Sponsored by Driving the Field of Oligonucleotide Therapeutics State-of-the-Art Solutions for Oligonucleotide Characterization, Purification, and Manufacturing / Chapter 1: Introduction to Oligonucleotide Therapeutics / Chapter 2: Challenges for Oligonucleotide Synthesis and Production / Chapter…